Skip NavigationSkip to Content
Return Return to Search Results

Cancer Immunotherapy and Immunomonitoring (CITIM): Redefining Cancer Therapy

  1. Author:
    Malyguine, A.
    Umansky, V.
    Shurin, M. R.

  2. Author Address

    [Malyguine, Anatoli] NCI, Lab Cell Mediated Immun, SAIC Frederick Inc, Frederick, MD 21702 USA. [Umansky, Victor] German Canc Res Ctr, D-6900 Heidelberg, Germany. [Shurin, Michael R.] Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA. [Shurin, Michael R.] Univ Pittsburgh, Med Ctr, Dept Immunol, Pittsburgh, PA USA.;Malyguine, A, NCI, Lab Cell Mediated Immun, SAIC Frederick Inc, Frederick, MD 21702 USA.;malyguinea@mail.nih.gov
    1. Year: 2009
  2. Journal: Journal of Immunotoxicology
    1. 6
    2. 4
    3. Pages: 205-208
  4. Type of Article: Article
  5. ISSN: 1547-691X
  1. Abstract:

    The immune system is a critical element involved in the control of tumor development and progression. While we have learned how to manipulate the immune system to generate tumor-specific immune responses, cancer immunotherapy has not yet delivered substantial clinical benefits. It has become increasingly clear that tumor-induced abnormalities in the immune system not only hamper natural tumor immune surveillance, but also limit the effect of cancer immunotherapy. If the results of recent studies are of any indication, then we are on the verge of a real breakthrough in our understanding of the immunobiology of tumor-host interactions and of ways to manipulate it. This 1(st) International Conference on "Cancer Immunotherapy and Immunomonitoring (CITIM)" was the first meeting in Eastern Europe to specifically focus on the issue of immune regulation in the tumor environment, cancer immunotherapy, and immunomonitoring of immunotherapeutic clinical trials. This CITIM Conference held in Kiev, Ukraine, was comprised from eight plenary sessions and two special selected poster presentation sessions. Selected contributions from the participants of the Conference are presented in this issue of the Journal of Immunotoxicology.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.3109/15476910903120932
  3. View record in Web of Science®
  4. WOS: 000275001500001

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel